Kaitlyn D’Onofrio

DocwireNews

Patients younger than 50 years of age had superior short- and long-term outcomes following open descending/ thoracoabdominal aortic aneurysm (D/TAAA) repairs when compared to older groups in a recent study presented at the 65th Annual Meeting &amp; Exhibition of the Southern Thoracic Surgical Association.Thoracic Endovascular Aortic Repair (TEVAR) is the primary treatment option for older, high-risk patients, but the treatment has a high failure rate according to Akiko Tanaka, MD, PhD, of McGovern Medical School at UTHealth in Houston, Texas. Tanaka and her team questioned whether younger patients and patients with connective tissue disorders should undergo TEVAR.&ldquo;The purpose of this study is to provide the outcomes after descending thoracic and thoracoabdominal aortic aneurysm repair in [the] younger patient population to redefine the indications for open repairs in the modern [TEVAR] era,&rdquo; said Tanaka.Researchers conducted a single-center, retrospective analysis of D/TAAA patients between 1991 and 2017. According to the abstract, 1,896 patients were classified by age younger than 50 years (87%, n = 1,642) and older than 50 years and compared perioperative and postoperative outcomes.Younger patients were more likely to be Marfan patients (23% vs. 1%, P &lt; 0.001). The younger group also had significantly more chronic dissection (63% vs. 26%, P &lt; 0.001), family history of aortic aneurysms (15% vs. 6%, P &lt; 0.001), redo (18% vs. 12%, P = 0.012), and prior ascending aortic repair (36% vs. 17%, P &lt; 0.001), and fewer comorbidities (hypertension, chronic lung disease, chronic kidney disease, and coronary artery disease, all P &lt; 0.001). The groups had similar frequencies of female sex (33% vs. 38%, P = 0.207) and emergent repairs (9% vs. 9%, P = 0.797). Extent II repairs were much more common in the younger cohort (28% vs. 15%, P &lt; 0.001), and postoperative adverse events were significantly lower (30-day mortality, 6% vs. 17%, P &lt; 0.001; paraplegia, 2% vs. 5%, P = 0.011; acute kidney injury, 18% vs 30%, P &lt; 0.001). Adjusted analyses identified long-term mortality risks as low glomerular filtration rate, extent II repairs, emergency, redo, coronary artery disease, smoking, and cerebrovascular disease, but found that younger age was a protective factor (hazard ratio: 0.594, P = 0.001).According to Tanaka, younger patients had lower postoperative rates of respiratory failure (31% vs. 40%, P = 0.004), newly required dialysis (12% vs. 23%, P &lt; 0.001), and stroke (4% vs. 6%, P = 0.156), as well as slightly shorter length of stay (12 days vs. 14 days, P = 0.177). Younger patients also had lower rates of operative mortality (7% vs. 17%) but increased rates of aortic reintervention (12% vs. 4%) and treatment failure (4% vs. 1%). Younger patients had good postoperative survival rates, Tanaka stated; 10-year survival was more than 75%, and 25-year survival was 65%. &ldquo;Adding treatment failure to the survival&rdquo; rates didn&rsquo;t significantly change these results, she said.Both younger and older patients were at an increased risk of disabling complications as extent of repair increased, Tanaka said, adding that open surgical repair has a low treatment failure rate but younger patients&mdash;especially those with known connective disorder&mdash;should be closely followed.Invited discussant Bradley Leshnower, MD, of Emory University in Atlanta, noted that TEVAR is not as effective in cases involving aneurysms in chronic dissections, regardless of age.&ldquo;There has been a steady push for less invasive procedures overall in cardiac and aortic surgery,&rdquo; Leshnower said, adding that open surgery still remains a viable option in some circumstances. The current study serves as a benchmark to help guide whether open or endovascular surgeries should be performed on young patients, he added.

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Open Descending and Thoracoabdominal Repairs Safe in Younger Patients

STSA 2018

Patients younger than 50 years of age had superior short- and long-term outcomes following open descending/ thoracoabdominal aortic aneurysm (D/TAAA) repairs when compared to ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe